Abstract
The cellular and molecular mechanisms involved in many abnormalities described in Systemic Lupus Erythematosus (SLE) are still unclear. Some of these abnormalities referred to the hyperactivation of T lymphocytes and the enhanced secretion of MMP-9 by peripheral blood mononuclear cells (PBMCs). Therefore, in this paper we investigated the potential role of CD147 molecule in these abnormalities. Our results demonstrated that CD147 molecule is overexpressed on CD3+T lymphocytes from SLE patients when compared with CD3+T lymphocytes from healthy donors. Monoclonal anti-CD147 antibodies, MEM-M6/1 clone, were able to inhibit protein tyrosine phosphorylation only in CD3 × CD28 costimulated T lymphocytes from SLE patients. However, this monoclonal antibody was unable to inhibit the enhanced activity of MMP-9 secreted by SLE PBMCs. © 2007 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.
Author supplied keywords
Cite
CITATION STYLE
Pistol, G., Matache, C., Calugaru, A., Stavaru, C., Tanaseanu, S., Ionescu, R., … Stefanescu, M. (2007). Roles of CD147 on T lymphocytes activation and MMP-9 secretion in Systemic Lupus Erythematosus. Journal of Cellular and Molecular Medicine, 11(2), 339–348. https://doi.org/10.1111/j.1582-4934.2007.00022.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.